News + Press

SA Express News Reports on Texas Biomed Being at the Forefront of the Ebola Fight | 10.24.2014

Richard A. Marini with the San Antonio Express News reported in a story on October 14, 2014 how Texas Biomed is at the forefront of the Ebola fight. The institute has been working on an Ebola vaccine for the past 10 years. | Read the full story

KSAT 12 Streams Online the University of the Incarnate Panel Discussion on Ebola Which Includes Texas Biomed Scientist, Dr. Ricardo Carrion | 10.24.2014

Dr. Ricardo Carrion participated in an hour-long UIW panel discussion on Ebola this week which was streamed online by KSAT-12. | Read the full story

Mymetics’ Promising HIV Vaccine Candidate Obtains Funding to Begin Study at Texas Biomedical Research Institute | 09.30.2014

Epalinges, Switzerland, 29 September 2014 - Mymetics Corporation (OTCQB: MYMX), a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial. The study will be led by Dr. Ruth Ruprecht, Scientist & Director of the Texas Biomed AIDS Research Program. | Read the full story

News 4 San Antonio Story Highlights Ebola Research at Texas Biomed | 09.22.2014

Lauren Lea with News 4 San Antonio reported in a story on September 19 how Texas Biomed has been working to detect, treat and discover a vaccine for the deadly Ebola virus. | Read the full story

Research Milestone in CCHF Virus Could Help Identify New Treatments | 09.18.2014

New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factors essential for CCHFV infection. This discovery has the potential to lead to novel targets for therapeutic interventions against the pathogen. | Read the full story

Texas Biomed Gains $2.7 Million NIH Grant to Develop New Methods to Understand Genetic Basis of Diseases | 08.15.2014

The Texas Biomedical Research Institute has been awarded a $2.7 million grant from the U.S. National Institutes of Health to fund innovative approaches to genetics research aimed at developing new therapies for heart disease and other conditions with genetic components. | Read the full story

Robert Gracy Named Interim CEO at Texas Biomed | 07.22.2014

Robert W. Gracy, Ph.D., has been named Interim President and Chief Executive Officer of Texas Biomedical Research Institute, according to Board Chairman Richard Schlosberg. | Read the full story

Texas Biomed Regenerative Medicine Program Expands With Two New Research Scientists | 06.11.2014

Texas Biomedical Research Institute has recruited two new research scientists to its Southwest National Primate Research Center (SNPRC) who will focus on regenerative medicine, working with animal models to develop human stem cell therapies for medical conditions such as Parkinson’s disease, degenerative diseases of the eye and muscular dystrophy. Tiziano Barberi, PhD and Marcel M. Daadi, PhD join Texas Biomed as Associate Scientists in the SNPRC. | Read the full story

Trevett Announces Resignation as Texas Biomed CEO | 05.29.2014

SAN ANTONIO, May 28, 2014 - Texas Biomedical Research Institute has announced the resignation of Kenneth P. Trevett as its President and CEO, according to Board Chairman Richard Schlosberg. Trevett will continue in the position until a successor is hired. | Read the full story

A new method for isolating and genome sequencing malaria parasites will aid in the understanding of these infections | 05.08.2014

A new method for isolating and genome sequencing an individual malaria parasite cell has been developed by Texas Biomed researchers and their colleagues. This advance will allow scientists to improve their ability to identify the multiple types of malaria parasites infecting patients and lead to ways to best design drugs and vaccines to tackle this major global killer. | Read the full story